Office of the Director, National Institutes of Health; Notice of Meeting, 77595 [2023-24971]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 217 / Monday, November 13, 2023 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee to
the Director, National Institutes of
Health.
This will be a hybrid meeting held inperson and virtually and will be open to
the public as indicated below. Given the
capacity constraints of the venue, the
public is strongly encouraged to attend
virtually via NIH videocast. Individuals
who plan to attend in-person or view
the virtual meeting and need special
assistance or other reasonable
accommodations, should notify the
Contact Person listed below in advance
of the meeting. The meeting can be
accessed from the NIH Videocast at the
following link: https://
videocast.nih.gov/.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Advisory Committee
to the Director, National Institutes of Health.
Date: December 14, 2023.
Time: 9:00 a.m. to 4:45 p.m.
Agenda: Performing the Duties of the NIH
Director’s Report; NIH Public Access Plan;
Cancer Moonshot; Addressing the Mental
Health Crisis through Research; Addressing
the Public Health Threat of Post-Acute
Sequelae of SARS CoV–2 Infection (PASC)—
NIH RECOVER Initiative: Briefing for the
Advisory Council to the Director (ACD); The
Foundation for the National Institutes of
Health (FNIH); Other Business of the
Committee.
Date: December 15, 2023.
Time: 9:00 a.m. to 2:45 p.m.
Agenda: HeLA Genome Data Access
Working Group: Data Access Requests; NIHwide Collaborative Initiative on Climate
Change and Health; Clinical Trial
Stewardship; Accessibility Update; Update
from the ACD Working Group on Catalyzing
the Development and Use of Novel
Alternative Methods to Advance Biomedical
Research; Update from the ACD Working
Group on Re-envisioning NIH-Supported
Postdoctoral Training; Other Business of the
Committee.
VerDate Sep<11>2014
17:12 Nov 09, 2023
Jkt 262001
Place: National Institutes of Health,
Building 1, Wilson Hall, One Center Drive,
Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff
Assistant, National Institutes of Health,
Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892,
301–496–2433, shawcy@od.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors attending a meeting on
campus or at an off-campus federal facility
will be asked to show one form of
identification (for example, a governmentissued photo ID, driver’s license, or passport)
and to state the purpose of their visit.
Information is also available on the
Institute’s/Center’s home page: https://
acd.od.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24971 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
77595
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: December 18, 2023.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 903 South 4th Street, RML 31/3118,
Hamilton, MT 59840 (Virtual Meeting).
Contact Person: Kristin L. McNally, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 903
South 4th Street, RML 31/3118, Hamilton,
MT 59840, mcnallyk@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of
Federal Advisory Committee Policy.
[FR Doc. 2023–24964 Filed 11–9–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
E:\FR\FM\13NON1.SGM
13NON1
]]>Agencies
[Federal Register Volume 88, Number 217 (Monday, November 13, 2023)]
[Notices]
[Page 77595]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-24971]
[[Page 77595]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Advisory Committee
to the Director, National Institutes of Health.
This will be a hybrid meeting held in-person and virtually and will
be open to the public as indicated below. Given the capacity
constraints of the venue, the public is strongly encouraged to attend
virtually via NIH videocast. Individuals who plan to attend in-person
or view the virtual meeting and need special assistance or other
reasonable accommodations, should notify the Contact Person listed
below in advance of the meeting. The meeting can be accessed from the
NIH Videocast at the following link: https://videocast.nih.gov/.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Advisory Committee to the Director, National
Institutes of Health.
Date: December 14, 2023.
Time: 9:00 a.m. to 4:45 p.m.
Agenda: Performing the Duties of the NIH Director's Report; NIH
Public Access Plan; Cancer Moonshot; Addressing the Mental Health
Crisis through Research; Addressing the Public Health Threat of
Post-Acute Sequelae of SARS CoV-2 Infection (PASC)--NIH RECOVER
Initiative: Briefing for the Advisory Council to the Director (ACD);
The Foundation for the National Institutes of Health (FNIH); Other
Business of the Committee.
Date: December 15, 2023.
Time: 9:00 a.m. to 2:45 p.m.
Agenda: HeLA Genome Data Access Working Group: Data Access
Requests; NIH-wide Collaborative Initiative on Climate Change and
Health; Clinical Trial Stewardship; Accessibility Update; Update
from the ACD Working Group on Catalyzing the Development and Use of
Novel Alternative Methods to Advance Biomedical Research; Update
from the ACD Working Group on Re-envisioning NIH-Supported
Postdoctoral Training; Other Business of the Committee.
Place: National Institutes of Health, Building 1, Wilson Hall,
One Center Drive, Bethesda, MD 20892.
Contact Person: Cyndi Burrus-Shaw, Staff Assistant, National
Institutes of Health, Office of the Director, One Center Drive,
Building 1, Room 126, Bethesda, MD 20892, 301-496-2433,
[email protected].
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has procedures at https://www.nih.gov/about-nih/visitor-information/campus-access-security for
entrance into on-campus and off-campus facilities. All visitor
vehicles, including taxicabs, hotel, and airport shuttles will be
inspected before being allowed on campus. Visitors attending a
meeting on campus or at an off-campus federal facility will be asked
to show one form of identification (for example, a government-issued
photo ID, driver's license, or passport) and to state the purpose of
their visit.
Information is also available on the Institute's/Center's home
page: https://acd.od.nih.gov, where an agenda and any additional
information for the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: November 7, 2023.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee
Policy.
[FR Doc. 2023-24971 Filed 11-9-23; 8:45 am]
BILLING CODE 4140-01-P
